Christopher P. Loo

1.2k total citations
22 papers, 833 citations indexed

About

Christopher P. Loo is a scholar working on Immunology, Virology and Molecular Biology. According to data from OpenAlex, Christopher P. Loo has authored 22 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 8 papers in Virology and 5 papers in Molecular Biology. Recurrent topics in Christopher P. Loo's work include Immune Cell Function and Interaction (13 papers), HIV Research and Treatment (8 papers) and Reproductive System and Pregnancy (4 papers). Christopher P. Loo is often cited by papers focused on Immune Cell Function and Interaction (13 papers), HIV Research and Treatment (8 papers) and Reproductive System and Pregnancy (4 papers). Christopher P. Loo collaborates with scholars based in United States, Sweden and Brazil. Christopher P. Loo's co-authors include Douglas F. Nixon, Frederick Hecht, Gerald Spotts, Jakob Michaëlsson, Joan M. Chapman, Esper G. Kallás, Amanda W. Lund, Ryan S. Lane, Michael Rosenberg and Brian Long and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Christopher P. Loo

22 papers receiving 822 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher P. Loo United States	14	511	232	175	124	121	22	833
Nicole Prada United States	14	332 0.6×	194 0.8×	196 1.1×	285 2.3×	144 1.2×	16	839
Núria Gonzàlez Spain	17	258 0.5×	328 1.4×	103 0.6×	204 1.6×	85 0.7×	28	664
Gao‐Hong Zhang China	14	191 0.4×	161 0.7×	133 0.8×	250 2.0×	91 0.8×	46	698
Soulaïma Chamat Lebanon	17	336 0.7×	146 0.6×	33 0.2×	220 1.8×	90 0.7×	33	905
Shahzada Khan United States	14	235 0.5×	79 0.3×	82 0.5×	228 1.8×	175 1.4×	22	689
Barbara Waurzyniak United States	16	168 0.3×	120 0.5×	115 0.7×	101 0.8×	51 0.4×	31	563
Mitsuo Baba Japan	13	302 0.6×	71 0.3×	76 0.4×	156 1.3×	134 1.1×	19	756
Г. В. Черепнев Russia	13	368 0.7×	48 0.2×	133 0.8×	242 2.0×	369 3.0×	37	999
Greg L. Beilhartz Canada	16	138 0.3×	214 0.9×	71 0.4×	432 3.5×	89 0.7×	26	787
Natacha Mérindol Canada	17	285 0.6×	87 0.4×	130 0.7×	185 1.5×	68 0.6×	60	861

Countries citing papers authored by Christopher P. Loo

Since Specialization

Citations

This map shows the geographic impact of Christopher P. Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Loo more than expected).

Fields of papers citing papers by Christopher P. Loo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Loo. The network helps show where Christopher P. Loo may publish in the future.

Co-authorship network of co-authors of Christopher P. Loo

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Loo. A scholar is included among the top collaborators of Christopher P. Loo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Loo. Christopher P. Loo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loo, Christopher P., et al.. (2024). IL-12/IL-23 Blockade Reveals Patterns of Asynchronous Inflammation in Pyoderma Gangrenosum. Journal of Investigative Dermatology. 145(5). 1209–1212.e3. 3 indexed citations

Romine, Kyle A., Kevin MacPherson‐Hawthorne, Yoko Kosaka, et al.. (2023). BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8+ T cells. Leukemia. 37(3). 580–592. 17 indexed citations

Lane, Ryan S., Julia Femel, Christopher P. Loo, et al.. (2018). IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin. The Journal of Experimental Medicine. 215(12). 3057–3074. 126 indexed citations

Loo, Christopher P., Nicholas A. Nelson, Ryan S. Lane, et al.. (2017). Lymphatic Vessels Balance Viral Dissemination and Immune Activation following Cutaneous Viral Infection. Cell Reports. 20(13). 3176–3187. 53 indexed citations

Loo, Christopher P., et al.. (2014). Nanostructured lipid carriers (NLC) for efficient delivery of palm phytonutrients. Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia). 4 indexed citations

Yazdi, Iman K., Matthew B. Murphy, Christopher P. Loo, et al.. (2014). Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against Staphylococcus aureus. Journal of Tissue Engineering. 5. 2746265981–2746265981. 18 indexed citations

Loo, Christopher P., et al.. (2014). Characterization of Free and Porous Silicon-Encapsulated Superparamagnetic Iron Oxide Nanoparticles as Platforms for the Development of Theranostic Vaccines. SHILAP Revista de lepidopterología. 2(1). 51–69. 8 indexed citations

Wang, Mingjun, Bingnan Yin, Satoko Matsueda, et al.. (2013). Identification of Special AT-Rich Sequence Binding Protein 1 as a Novel Tumor Antigen Recognized by CD8+ T Cells: Implication for Cancer Immunotherapy. PLoS ONE. 8(2). e56730–e56730. 9 indexed citations

Matsueda, Satoko, Mingjun Wang, Jinsheng Weng, et al.. (2012). Identification of Prostate-Specific G-Protein Coupled Receptor as a Tumor Antigen Recognized by CD8+ T Cells for Cancer Immunotherapy. PLoS ONE. 7(9). e45756–e45756. 13 indexed citations

10.

Snyder‐Cappione, Jennifer, Christopher P. Loo, Brian Long, et al.. (2010). NK Cells and CD1d‐restricted NKT Cells Respond in Different Ways with Divergent Kinetics to IL‐2 Treatment in Primary HIV‐1 Infection. Scandinavian Journal of Immunology. 73(2). 141–146. 11 indexed citations

11.

Snyder‐Cappione, Jennifer, Christopher P. Loo, Karina I. Carvalho, et al.. (2009). Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression. AIDS. 23(15). 1965–1970. 33 indexed citations

12.

Loo, Christopher P., Brian Long, Frederick Hecht, Douglas F. Nixon, & Jakob Michaëlsson. (2009). HIV-1-Specific T Cell-Dependent Natural Killer (NK) Cell Activation: Major Contribution by NK Cells to Interferon-γ Production in Response to HIV-1 Antigens. AIDS Research and Human Retroviruses. 25(6). 603–605. 4 indexed citations

13.

Ndhlovu, Lishomwa C., Jennifer Snyder‐Cappione, Karina I. Carvalho, et al.. (2009). Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease. Clinical & Experimental Immunology. 158(3). 294–299. 18 indexed citations

14.

Long, Brian, Jakob Michaëlsson, Christopher P. Loo, et al.. (2007). Elevated Frequency of Gamma Interferon-Producing NK Cells in Healthy Adults Vaccinated against Influenza Virus. Clinical and Vaccine Immunology. 15(1). 120–130. 56 indexed citations

15.

Long, Brian, Christopher P. Loo, Jakob Michaëlsson, et al.. (2007). Natural Killer Cells in Perinatally HIV-1-Infected Children Exhibit Less Degranulation Compared to HIV-1-Exposed Uninfected Children and Their Expression of KIR2DL3, NKG2C, and NKp46 Correlates with Disease Severity. The Journal of Immunology. 179(5). 3362–3370. 56 indexed citations

16.

Snyder‐Cappione, Jennifer, Douglas F. Nixon, Christopher P. Loo, et al.. (2007). Individuals with Pulmonary Tuberculosis Have Lower Levels of Circulating CD1d‐Restricted NKT Cells. The Journal of Infectious Diseases. 195(9). 1361–1364. 54 indexed citations

17.

Michaëlsson, Jakob, Brian Long, Christopher P. Loo, et al.. (2007). Immune Reconstitution of CD56^dimNK Cells in Individuals with Primary HIV‐1 Infection Treated with Interleukin‐2. The Journal of Infectious Diseases. 197(1). 117–125. 22 indexed citations

18.

Northfield, John, Christopher P. Loo, Jason D. Barbour, et al.. (2007). Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8⁺T_EMRACells in Early Infection Are Linked to Control of HIV-1 Viremia and Predict the Subsequent Viral Load Set Point. Journal of Virology. 81(11). 5759–5765. 64 indexed citations

19.

Ndhlovu, Lishomwa C., Christopher P. Loo, Gerald Spotts, Douglas F. Nixon, & Frederick Hecht. (2007). FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection. Journal of Leukocyte Biology. 83(2). 254–262. 66 indexed citations

20.

Nixon, Douglas F., Christopher P. Loo, Érika Ono, et al.. (2006). Strong HIV-1-Specific T Cell Responses in HIV-1-Exposed Uninfected Infants and Neonates Revealed after Regulatory T Cell Removal. PLoS ONE. 1(1). e102–e102. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact